MTUM 📈 iShares MSCI USA Momentum - Overview
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46432F3964 • Large Blend
MTUM: Stocks, US, Equities, Momentum, Investments
The iShares MSCI USA Momentum Factor ETF, listed on BATS under the ticker MTUM, is designed to track the performance of the MSCI USA Momentum Index. This index is composed of stocks that exhibit higher momentum characteristics compared to the traditional market capitalization-weighted MSCI USA Index. By focusing on momentum, the fund aims to capture the performance of stocks that are experiencing an upward trend in their prices, which can be an indicator of their future growth potential. The fund's investment strategy involves investing at least 80% of its assets in the component securities of its underlying index, as well as in investments that have similar economic characteristics to these component securities.
The MSCI USA Momentum Index uses a rules-based methodology to select stocks from the MSCI USA Index, which is a broad market capitalization-weighted index of US stocks. The momentum index is designed to capture the performance of stocks with high momentum, which can be measured by factors such as price appreciation, earnings momentum, and other metrics. By tracking this index, the iShares MSCI USA Momentum Factor ETF provides investors with a way to gain exposure to US stocks with strong momentum characteristics, which can be an attractive option for those looking to capitalize on growth opportunities in the US market. The fund is listed in the United States and has an ISIN of US46432F3964, categorizing it as a large growth ETF.
As an ETF, the iShares MSCI USA Momentum Factor ETF offers investors the benefits of diversification, liquidity, and transparency, making it an attractive option for those looking to add momentum-driven US stocks to their portfolios. The fund's large growth category classification indicates that it is focused on investing in larger-cap US stocks with strong growth potential, which can provide a relatively stable source of returns for investors. With its listing on BATS and availability through various online brokerages, the fund is accessible to a wide range of investors, from individual traders to institutional investors. More information about the fund can be found on the iShares website at http://www.ishares.com.
Additional Sources for MTUM ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
MTUM ETF Overview
Market Cap in USD | 13,648m |
Category | Large Blend |
TER | 0.15% |
IPO / Inception | 2013-04-16 |
MTUM ETF Ratings
Growth 5y | 57.7% |
Fundamental | - |
Dividend | 21.5% |
Rel. Strength Industry | 41.2 |
Analysts | - |
Fair Price Momentum | 213.52 USD |
Fair Price DCF | - |
MTUM Dividends
Dividend Yield 12m | 0.38% |
Yield on Cost 5y | 0.67% |
Annual Growth 5y | -9.80% |
Payout Consistency | 88.1% |
MTUM Growth Ratios
Growth Correlation 3m | 55.7% |
Growth Correlation 12m | 91% |
Growth Correlation 5y | 52.4% |
CAGR 5y | 12.12% |
CAGR/Mean DD 5y | 1.01 |
Sharpe Ratio 12m | 1.62 |
Alpha | 9.79 |
Beta | 1.06 |
Volatility | 21.93% |
Current Volume | 795k |
Average Volume 20d | 933.5k |
As of January 04, 2025, the stock is trading at USD 211.26 with a total of 795,000 shares traded.
Over the past week, the price has changed by +0.43%, over one month by -1.52%, over three months by +5.05% and over the past year by +39.39%.
Partly, yes. Based on ValueRay Analyses, iShares MSCI USA Momentum (BATS:MTUM) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 57.70 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MTUM as of January 2025 is 213.52. This means that MTUM is currently overvalued and has a potential downside of 1.07%.
iShares MSCI USA Momentum has no consensus analysts rating.
According to ValueRays Forecast Model, MTUM iShares MSCI USA Momentum will be worth about 237.9 in January 2026. The stock is currently trading at 211.26. This means that the stock has a potential upside of +12.62%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 237.9 | 12.6% |